Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Murray-Segal

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Autoimmunity|November 7, 2017
CD39 and CD73 activity are protective in a mouse model of antiphospholipid antibody-induced miscarriagesAnushka N Samudra, Karen M Dwyer, Carly Selan, et al.
Metabolites|March 27, 2026
Remodeling of the Mouse Liver and Skeletal Muscle Metabolome in Response to Continuous Acute Exercise and Disruption of AMPK-Glycogen InteractionsMehdi R Belhaj, David I Broadhurst, Thomas Dignan, et al.
Diabetes|February 1, 2013
The protective effects of CD39 overexpression in multiple low-dose streptozotocin-induced diabetes in miceJoanne S J Chia, Jennifer L McRae, Helen E Thomas, et al.
Cell Reports|February 16, 2022
An AMPKα2-specific phospho-switch controls lysosomal targeting for activationKaitlin R Morrison, William J Smiles, Naomi X Y Ling, et al.
Molecular Metabolism|July 2, 2020
Genetic loss of AMPK-glycogen binding destabilises AMPK and disrupts metabolismNolan J Hoffman, Jamie Whitfield, Natalie R Janzen, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 15, 2024
The AMPK activator ATX-304 alters cellular metabolism to protect against cisplatin-induced acute kidney injuryMarina Katerelos, Kurt Gleich, Geoff Harley, et al.
Hepatology Communications|January 9, 2019
Inhibition of Adenosine Monophosphate-Activated Protein Kinase-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Signaling Leads to Hypercholesterolemia and Promotes Hepatic Steatosis and Insulin ResistanceKim Loh, Shanna Tam, Lisa Murray-Segal, et al.
Cell Reports|December 21, 2022
Blocking AMPK β1 myristoylation enhances AMPK activity and protects mice from high-fat diet-induced obesity and hepatic steatosisKatyayanee Neopane, Natalie Kozlov, Florentina Negoita, et al.
The FEBS Journal|March 21, 2020
The myokine meteorin-like (metrnl) improves glucose tolerance in both skeletal muscle cells and mice by targeting AMPKα2Jung Ok Lee, Won Seok Byun, Min Ju Kang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 1, 2019
ATP synthase inhibitory factor 1 (IF1), a novel myokine, regulates glucose metabolism by AMPK and Akt dual pathwaysHye Jeong Lee, Jiyoung Moon, InHyeok Chung, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Autoimmunity|November 7, 2017
CD39 and CD73 activity are protective in a mouse model of antiphospholipid antibody-induced miscarriagesAnushka N Samudra, Karen M Dwyer, Carly Selan, et al.
Metabolites|March 27, 2026
Remodeling of the Mouse Liver and Skeletal Muscle Metabolome in Response to Continuous Acute Exercise and Disruption of AMPK-Glycogen InteractionsMehdi R Belhaj, David I Broadhurst, Thomas Dignan, et al.
Diabetes|February 1, 2013
The protective effects of CD39 overexpression in multiple low-dose streptozotocin-induced diabetes in miceJoanne S J Chia, Jennifer L McRae, Helen E Thomas, et al.
Cell Reports|February 16, 2022
An AMPKα2-specific phospho-switch controls lysosomal targeting for activationKaitlin R Morrison, William J Smiles, Naomi X Y Ling, et al.
Molecular Metabolism|July 2, 2020
Genetic loss of AMPK-glycogen binding destabilises AMPK and disrupts metabolismNolan J Hoffman, Jamie Whitfield, Natalie R Janzen, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 15, 2024
The AMPK activator ATX-304 alters cellular metabolism to protect against cisplatin-induced acute kidney injuryMarina Katerelos, Kurt Gleich, Geoff Harley, et al.
Hepatology Communications|January 9, 2019
Inhibition of Adenosine Monophosphate-Activated Protein Kinase-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Signaling Leads to Hypercholesterolemia and Promotes Hepatic Steatosis and Insulin ResistanceKim Loh, Shanna Tam, Lisa Murray-Segal, et al.
Cell Reports|December 21, 2022
Blocking AMPK β1 myristoylation enhances AMPK activity and protects mice from high-fat diet-induced obesity and hepatic steatosisKatyayanee Neopane, Natalie Kozlov, Florentina Negoita, et al.
The FEBS Journal|March 21, 2020
The myokine meteorin-like (metrnl) improves glucose tolerance in both skeletal muscle cells and mice by targeting AMPKα2Jung Ok Lee, Won Seok Byun, Min Ju Kang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 1, 2019
ATP synthase inhibitory factor 1 (IF1), a novel myokine, regulates glucose metabolism by AMPK and Akt dual pathwaysHye Jeong Lee, Jiyoung Moon, InHyeok Chung, et al.
Pageof 2